世界の急性虚血性脳卒中治療市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP09795)
◆英語タイトル:Global Acute Ischemic Stroke Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP09795
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、急性虚血性脳卒中治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。急性虚血性脳卒中治療の種類別市場規模(血栓溶解療法、降圧療法、抗血小板療法、抗凝固薬)、用途別市場規模(病院、外来手術センター、診断センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Bayer、Sanofi、Boehringer Ingelheim、Pfizer、Roche、Daiichi Sankyo、Biogen
・地域別グローバル市場分析 2015年-2020年
・急性虚血性脳卒中治療の北米市場(アメリカ、カナダ、メキシコ)
・急性虚血性脳卒中治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・急性虚血性脳卒中治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・急性虚血性脳卒中治療の南米市場(ブラジル、アルゼンチン)
・急性虚血性脳卒中治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:血栓溶解療法、降圧療法、抗血小板療法、抗凝固薬
・用途別分析:病院、外来手術センター、診断センター
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Acute Ischemic Stroke Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Acute Ischemic Stroke Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Acute Ischemic Stroke Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Acute Ischemic Stroke Therapeutics market has been segmented into:
Thrombolytic Therapeutics
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants

By Application, Acute Ischemic Stroke Therapeutics has been segmented into:
Hospitals
Ambulatory Surgical Center
Diagnostic Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Ischemic Stroke Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Ischemic Stroke Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Ischemic Stroke Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Acute Ischemic Stroke Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Acute Ischemic Stroke Therapeutics Market Share Analysis
Acute Ischemic Stroke Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Ischemic Stroke Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Ischemic Stroke Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Acute Ischemic Stroke Therapeutics are:
Bayer
Sanofi
Boehringer Ingelheim
Pfizer
Roche
Daiichi Sankyo
Biogen

【レポートの目次】

Table of Contents

1 Acute Ischemic Stroke Therapeutics Market Overview
1.1 Product Overview and Scope of Acute Ischemic Stroke Therapeutics
1.2 Classification of Acute Ischemic Stroke Therapeutics by Type
1.2.1 Global Acute Ischemic Stroke Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type in 2019
1.2.3 Thrombolytic Therapeutics
1.2.4 Antihypertensive Therapeutics
1.2.5 Antiplatelet Therapeutics
1.2.6 Anticoagulants
1.3 Global Acute Ischemic Stroke Therapeutics Market by Application
1.3.1 Overview: Global Acute Ischemic Stroke Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Diagnostic Centers
1.4 Global Acute Ischemic Stroke Therapeutics Market by Regions
1.4.1 Global Acute Ischemic Stroke Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Ischemic Stroke Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Ischemic Stroke Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Ischemic Stroke Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Ischemic Stroke Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Ischemic Stroke Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Ischemic Stroke Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Acute Ischemic Stroke Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Acute Ischemic Stroke Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim SWOT Analysis
2.3.4 Boehringer Ingelheim Product and Services
2.3.5 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Acute Ischemic Stroke Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Acute Ischemic Stroke Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Daiichi Sankyo
2.6.1 Daiichi Sankyo Details
2.6.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Daiichi Sankyo SWOT Analysis
2.6.4 Daiichi Sankyo Product and Services
2.6.5 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biogen SWOT Analysis
2.7.4 Biogen Product and Services
2.7.5 Biogen Acute Ischemic Stroke Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Ischemic Stroke Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Ischemic Stroke Therapeutics Players Market Share
3.2.2 Top 10 Acute Ischemic Stroke Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Ischemic Stroke Therapeutics Revenue and Market Share by Regions
4.2 North America Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Acute Ischemic Stroke Therapeutics Revenue by Countries
5.1 North America Acute Ischemic Stroke Therapeutics Revenue by Countries (2015-2020)
5.2 USA Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Acute Ischemic Stroke Therapeutics Revenue by Countries
6.1 Europe Acute Ischemic Stroke Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Ischemic Stroke Therapeutics Revenue by Countries
7.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Revenue by Countries (2015-2020)
7.2 China Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Acute Ischemic Stroke Therapeutics Revenue by Countries
8.1 South America Acute Ischemic Stroke Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Ischemic Stroke Therapeutics by Countries
9.1 Middle East & Africa Acute Ischemic Stroke Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Ischemic Stroke Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Ischemic Stroke Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Ischemic Stroke Therapeutics Market Forecast by Type (2019-2024)
10.3 Thrombolytic Therapeutics Revenue Growth Rate (2015-2025)
10.4 Antihypertensive Therapeutics Revenue Growth Rate (2015-2025)
10.5 Antiplatelet Therapeutics Revenue Growth Rate (2015-2025)
10.6 Anticoagulants Revenue Growth Rate (2015-2025)
11 Global Acute Ischemic Stroke Therapeutics Market Segment by Application
11.1 Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Acute Ischemic Stroke Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Center Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Acute Ischemic Stroke Therapeutics Market Size Forecast (2021-2025)
12.1 Global Acute Ischemic Stroke Therapeutics Market Size Forecast (2021-2025)
12.2 Global Acute Ischemic Stroke Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Acute Ischemic Stroke Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Acute Ischemic Stroke Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Ischemic Stroke Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Acute Ischemic Stroke Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Ischemic Stroke Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Bayer、Sanofi、Boehringer Ingelheim、Pfizer、Roche、Daiichi Sankyo、Biogen

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の急性虚血性脳卒中治療市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Acute Ischemic Stroke Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。